uveitis
Information
- Disease name
- uveitis
- Disease ID
- DOID:13141
- Description
- "An uveal disease is characterized by inflammation of any of the layers of the uvea of the eye, which includes the iris, ciliary body, and choroid." [url:https\://www.mayoclinic.org/diseases-conditions/uveitis/symptoms-causes/syc-20378734]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03889860 | Active, not recruiting | Objective Choroidal Thickness Measurements in Uveitis | September 1, 2018 | January 1, 2026 | |
| NCT04088409 | Active, not recruiting | Phase 3 | A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis | October 16, 2019 | July 21, 2028 |
| NCT06260449 | Active, not recruiting | N/A | Different Treatment Approaches of Presumed Trematode-Induced Uveitis | October 21, 2023 | December 21, 2024 |
| NCT03828019 | Active, not recruiting | Phase 3 | Adalimumab vs. Conventional Immunosuppression for Uveitis Trial | September 16, 2019 | September 17, 2024 |
| NCT03816397 | Active, not recruiting | Phase 4 | Adalimumab in JIA-associated Uveitis Stopping Trial | March 15, 2020 | July 30, 2025 |
| NCT05384249 | Active, not recruiting | Phase 2 | Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis | August 23, 2022 | August 7, 2025 |
| NCT05180526 | Active, not recruiting | Phase 4 | Assessment of Safety , Clinical Efficacy With QLETLI in Non-infectious Uveitis (UV) | December 27, 2021 | December 30, 2024 |
| NCT05385757 | Active, not recruiting | UNICORNS: Uveitis in Childhood Prospective National Cohort Study | October 22, 2020 | December 2024 | |
| NCT06070935 | Active, not recruiting | Nailfold Capillaroscopic Assessment in Pediatric Uveitis Patients | January 1, 2024 | June 30, 2024 | |
| NCT04704609 | Active, not recruiting | Imaging Quantification of Inflammation (IQI) | September 22, 2019 | September 30, 2025 | |
| NCT00001867 | Completed | Effect of Pregnancy on Uveitis | September 1999 | September 2000 | |
| NCT00021645 | Completed | Phase 1 | Vitamin E to Treat Uveitis-Associated Macular Edema | July 2001 | June 2004 |
| NCT00043667 | Completed | Phase 2 | Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis | August 2002 | October 2004 |
| NCT00070759 | Completed | Phase 2 | Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis | October 6, 2003 | October 2, 2006 |
| NCT00078689 | Completed | Phase 1 | Daclizumab and Sirolimus to Treat Uveitis | March 3, 2004 | July 18, 2008 |
| NCT00089739 | Completed | Immune Indicators of Uveitis | August 9, 2004 | October 28, 2008 | |
| NCT00116090 | Completed | Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study | June 16, 2005 | April 21, 2008 | |
| NCT00132691 | Completed | Phase 4 | Multicenter Uveitis Steroid Treatment (MUST) Trial | September 2005 | December 2010 |
| NCT00273390 | Completed | N/A | A Clinical Trial of Infliximab for Uveitis | August 2001 | December 2006 |
| NCT00280826 | Completed | Phase 1 | Efalizumab to Treat Uveitis | January 2006 | February 2009 |
| NCT00331331 | Completed | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease | February 14, 2007 | ||
| NCT04706741 | Completed | Phase 2 | A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis | January 6, 2022 | November 14, 2022 |
| NCT00357266 | Completed | Differences in Genes and Proteins in Active and Controlled Uveitis | February 1, 2002 | October 24, 2007 | |
| NCT00379275 | Completed | Eye and Immunogenetic Features of Sarcoidosis | September 18, 2006 | December 10, 2007 | |
| NCT00403832 | Completed | N/A | Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients | August 2005 | February 2007 |
| NCT00404482 | Completed | Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis | January 1991 | August 2006 | |
| NCT00407056 | Completed | Phase 3 | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis | August 2002 | June 2003 |
| NCT00444743 | Completed | Phase 2 | Phase 2 Study of MM-093 to Treat Patients With Uveitis | February 2007 | |
| NCT00476593 | Completed | N/A | Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications | September 2005 | December 2010 |
| NCT00498355 | Completed | Phase 1/Phase 2 | Lucentis for Inflammatory Macular Edema Trial | July 2007 | December 2009 |
| NCT04690829 | Completed | Biomarkers in Ocular Inflammation and Uveitis | December 29, 2020 | November 16, 2022 | |
| NCT00501579 | Completed | Phase 3 | Study of Difluprednate in the Treatment of Uveitis | ||
| NCT00525902 | Completed | Phase 2 | Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis | January 2008 | September 2010 |
| NCT04183387 | Completed | Phase 2 | Simvastatin in Uveitis | September 2014 | January 2016 |
| NCT00543296 | Completed | Phase 4 | Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment | March 2004 | July 2007 |
| NCT00552019 | Completed | Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT) | October 2007 | April 2009 | |
| NCT00615693 | Completed | Phase 2 | Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis | July 2008 | |
| NCT00647439 | Completed | Genetics and Markers of Degenerative and Inflammatory Eye Diseases | March 27, 2008 | December 4, 2018 | |
| NCT00676624 | Completed | Infectious Causes of Uveitis | April 2008 | September 2010 | |
| NCT00789984 | Completed | Corneal Specular Microscopy in Infectious and Noninfectious Uveitis | |||
| NCT00790803 | Completed | N/A | Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema | March 2009 | March 2012 |
| NCT00791726 | Completed | Microperimetry in Macular Edema | November 2008 | ||
| NCT00803816 | Completed | Phase 2 | Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A | November 2007 | December 2010 |
| NCT00827086 | Completed | Influencing Factors in Uveitis | March 2008 | July 2011 | |
| NCT04148365 | Completed | Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents | February 14, 2020 | May 30, 2021 | |
| NCT00874471 | Completed | Uveitis Gene-Expression Profiling | June 2005 | ||
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT03899922 | Completed | Monitoring Drug-induced Uveitis | April 1, 2019 | April 4, 2023 | |
| NCT00908466 | Completed | Phase 1 | Sirolimus as Therapeutic Approach to Uveitis | July 2009 | February 2013 |
| NCT00917670 | Completed | Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma | May 2009 | December 2009 | |
| NCT00943982 | Completed | Phase 1 | The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma | July 17, 2009 | June 24, 2010 |
| NCT03871361 | Completed | Phase 2 | Abatacept in Patients With Birdshot HLA A29 Uveitis | April 1, 2019 | December 1, 2023 |
| NCT01060787 | Completed | Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant | February 4, 2016 | June 7, 2019 | |
| NCT03753893 | Completed | Ocular Manifestations in Rheumatic Diseases | May 1, 2013 | November 1, 2021 | |
| NCT03646890 | Completed | Epidemiology and Clinical Features of Uveitis in a Tertiary Referral | January 1, 2002 | July 31, 2018 | |
| NCT03584724 | Completed | Early Phase 1 | Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis | December 19, 2018 | December 30, 2020 |
| NCT01124838 | Completed | Phase 3 | Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis | August 2010 | May 2015 |
| NCT01138657 | Completed | Phase 3 | Efficacy and Safety of Adalimumab in Patients With Active Uveitis | August 2010 | August 2014 |
| NCT01148225 | Completed | Phase 3 | A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis | November 23, 2010 | May 21, 2018 |
| NCT01162070 | Completed | N/A | Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis | June 2010 | July 2014 |
| NCT01170481 | Completed | Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema | July 2009 | April 2011 | |
| NCT03554824 | Completed | Psychosocial Outcomes and Transition Readiness in Uveitis | January 3, 2018 | August 14, 2018 | |
| NCT01195948 | Completed | Phase 1/Phase 2 | Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis | August 2010 | February 2014 |
| NCT01232920 | Completed | Phase 3 | First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial | October 2010 | June 2012 |
| NCT03531853 | Completed | N/A | OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers | November 14, 2018 | March 10, 2021 |
| NCT01279954 | Completed | Phase 2 | Abatacept in the Treatment of Uveitis | January 2012 | June 2017 |
| NCT03209219 | Completed | Phase 3 | Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis | June 30, 2017 | January 31, 2021 |
| NCT01306474 | Completed | Observation on the Treg in the Uveitis Patients | July 2009 | August 2010 | |
| NCT03206268 | Completed | RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal Compensation | May 1, 2015 | October 31, 2015 | |
| NCT01376362 | Completed | Phase 1/Phase 2 | Topical Interferon Gamma for Macular Edema Secondary to Uveitis | June 2011 | March 2012 |
| NCT01385826 | Completed | Phase 2/Phase 3 | Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis | June 29, 2011 | August 27, 2015 |
| NCT01495767 | Completed | Quality of Life in Juvenile Patients With Uveitis | January 2006 | July 2009 | |
| NCT03173144 | Completed | Chronic Inflammatory Disease, Lifestyle and Treatment Response | September 21, 2017 | April 30, 2021 | |
| NCT03155243 | Completed | Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice | June 20, 2017 | February 24, 2020 | |
| NCT03097315 | Completed | Phase 3 | Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis | April 4, 2017 | January 24, 2018 |
| NCT02998398 | Completed | Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital | October 2015 | June 29, 2016 | |
| NCT02975895 | Completed | N/A | Outcome of Different IOLs in Patients With and Without Uveitis | December 30, 2016 | March 17, 2022 |
| NCT01789320 | Completed | Phase 1/Phase 2 | Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis | February 2013 | March 2015 |
| NCT01829295 | Completed | Phase 3 | Methotrexate and Mycophenolate Mofetil for UVEITIS | August 2013 | August 9, 2018 |
| NCT01837056 | Completed | Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis | January 2011 | February 2012 | |
| NCT01859299 | Completed | Intestinal Bacteria and Ocular Inflammatory Disease | August 27, 2013 | ||
| NCT01870440 | Completed | Phase 4 | TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema | May 2013 | February 2015 |
| NCT01897935 | Completed | Flare Photometry in Uveitis Patients | June 2013 | April 2014 | |
| NCT01900431 | Completed | Phase 2 | Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis | October 2013 | April 2016 |
| NCT01905579 | Completed | N/A | Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry. | March 2013 | August 2013 |
| NCT02952001 | Completed | MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 | December 13, 2017 | May 22, 2018 | |
| NCT01983488 | Completed | Clinical Outcome in Uveitis | September 2011 | December 1, 2019 | |
| NCT02916017 | Completed | HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis | November 15, 2016 | October 14, 2020 | |
| NCT02911116 | Completed | Phase 2 | Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) | March 30, 2017 | May 28, 2020 |
| NCT02255032 | Completed | Phase 2 | Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis | October 2014 | January 2016 |
| NCT02819206 | Completed | N/A | Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs | June 7, 2013 | October 26, 2022 |
| NCT02764697 | Completed | Phase 4 | Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients | June 30, 2016 | December 20, 2016 |
| NCT02656381 | Completed | Uveitis/Intraocular Inflammatory Disease Biobank (iBank) | July 26, 2016 | May 4, 2023 | |
| NCT02374060 | Completed | Phase 3 | PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial | June 16, 2015 | January 4, 2018 |
| NCT02466217 | Completed | Phenomics in Autoimmune and Inflammatory Diseases | July 29, 2015 | July 18, 2022 | |
| NCT02490254 | Completed | Childhood Uveitis Initial Management and One-year Outcomes | November 1, 2014 | March 1, 2017 | |
| NCT02623426 | Completed | Phase 3 | Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial | March 9, 2017 | February 2, 2022 |
| NCT02620618 | Completed | Phase 1/Phase 2 | Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study | January 2013 | December 2014 |
| NCT02595398 | Completed | Phase 3 | Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis | November 17, 2015 | January 18, 2018 |
| NCT00001224 | Completed | Analysis of Eye Tissue | July 1987 | September 2002 | |
| NCT00001526 | Completed | Phase 1 | ANTI-TAC THERAPY FOR UVEITIS | June 4, 1996 | September 6, 2007 |
| NCT00001614 | Completed | Phase 1 | The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis | July 1997 | May 2000 |
| NCT00001734 | Completed | Screening for NEI Clinical Studies | March 23, 1998 | October 3, 2008 | |
| NCT00001737 | Completed | Phase 1 | Cyclosporin Implant to Treat Uveitis | May 1998 | March 2004 |
| NCT00001738 | Completed | Vascular Endothelial Growth Factor (VEGF) in Uveitis | August 1998 | June 2000 | |
| NCT00001862 | Completed | Phase 2 | TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis | February 1999 | March 2003 |
| NCT00001863 | Completed | Phase 2 | Leflunomide to Treat Uveitis | March 1999 | February 2003 |
| NCT00001865 | Completed | Phase 2 | HAT in Eye Complications of Behcet's Disease | July 1999 | June 2004 |
| NCT06431373 | Not yet recruiting | Phase 3 | A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (CLARITY) | August 23, 2024 | August 23, 2027 |
| NCT05105347 | Not yet recruiting | Phase 4 | Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis | November 10, 2021 | December 31, 2026 |
| NCT05349747 | Not yet recruiting | Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease | April 30, 2022 | August 2024 | |
| NCT06102408 | Not yet recruiting | Relevance and Efficiency of SecOnd Line Workup for Uveitis | November 15, 2023 | December 25, 2023 | |
| NCT06390436 | Not yet recruiting | Phase 4 | Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis | January 2025 | January 2029 |
| NCT04193020 | Recruiting | Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response | January 1, 2020 | January 1, 2026 | |
| NCT05486468 | Recruiting | Phase 3 | The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment | October 5, 2022 | December 2024 |
| NCT05388838 | Recruiting | N/A | Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With Uveitis | June 1, 2022 | December 1, 2025 |
| NCT02706704 | Recruiting | Phase 2 | Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis | February 2016 | February 2026 |
| NCT06273748 | Recruiting | RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age | February 10, 2022 | May 2, 2032 | |
| NCT05727540 | Recruiting | The Cohort Study of Uveitis Patients | February 20, 2023 | March 31, 2026 | |
| NCT05130385 | Recruiting | High Resolution Optical Coherence Tomography | November 30, 2021 | November 30, 2023 | |
| NCT02026128 | Recruiting | Optical Coherence Tomography (OCT) in Uveitis | March 2012 | December 2025 | |
| NCT04340505 | Recruiting | Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant | August 8, 2019 | March 1, 2025 | |
| NCT05200715 | Recruiting | AutoInflammatory Disease Alliance Registry (AIDA) | August 6, 2020 | August 6, 2030 | |
| NCT05286203 | Recruiting | N/A | Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing | June 6, 2022 | December 2026 |
| NCT03877575 | Recruiting | Lyon Uveitis Study | January 1, 2016 | January 1, 2025 | |
| NCT05683626 | Recruiting | Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag University Hospital | December 15, 2022 | December 30, 2023 | |
| NCT01746537 | Recruiting | Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography | June 2012 | June 2026 | |
| NCT06310837 | Recruiting | N/A | Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis | March 27, 2024 | September 27, 2025 |
| NCT05474729 | Recruiting | Phase 1/Phase 2 | Minocycline for Chronic Autoimmune Uveitis | December 1, 2021 | December 31, 2026 |
| NCT04798755 | Recruiting | Phase 3 | Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis | January 12, 2022 | October 1, 2025 |
| NCT05592717 | Recruiting | A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis | January 5, 2023 | November 1, 2026 | |
| NCT02357238 | Recruiting | Genetics of Uveitis | January 2011 | January 2030 | |
| NCT06161415 | Recruiting | Phase 1 | Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study | April 2024 | October 2024 |
| NCT02494492 | Suspended | Phase 1/Phase 2 | Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose | March 2013 | December 2017 |
| NCT00539370 | Terminated | Human Samples and Data Repository | August 29, 2007 | August 19, 2022 | |
| NCT04218565 | Terminated | Phase 2 | Golimumab for the Treatment of Refractory Behcet's Uveitis | February 15, 2020 | December 15, 2022 |
| NCT04296838 | Terminated | Phase 2/Phase 3 | Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF | October 12, 2019 | February 12, 2022 |
| NCT00001310 | Terminated | Tissue Studies of Human Eye Diseases | March 5, 1992 | September 16, 2015 | |
| NCT02769702 | Terminated | Phase 4 | Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis | June 2016 | January 6, 2017 |
| NCT05070728 | Terminated | Phase 3 | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert (FAI) | November 17, 2021 | April 12, 2023 |
| NCT02258854 | Terminated | Phase 3 | An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizumab Safety Data | March 2014 | December 2017 |
| NCT03554161 | Terminated | Phase 2 | Tocilizumab for the Treatment of Refractory Behcet's Uveitis | May 10, 2018 | February 1, 2021 |
| NCT00314665 | Terminated | Phase 4 | Use of Thalidomide in Chronic Uveitis | January 2004 | August 2006 |
| NCT01194674 | Terminated | Phase 1/Phase 2 | Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema | January 2011 | December 2011 |
| NCT00114062 | Terminated | Phase 2 | Study to Treat Uveitis Associated Macular Edema | September 2005 | December 2006 |
| NCT02907814 | Terminated | N/A | Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography | September 2016 | April 2018 |
| NCT01109433 | Terminated | Immunogenetic Mechanisms in Behcet's Disease | April 15, 2010 | December 17, 2018 | |
| NCT01939691 | Terminated | Phase 4 | Macular Edema Nepafenac vs. Difluprednate Uveitis Trial | September 12, 2018 | March 31, 2020 |
| NCT03660618 | Terminated | N/A | LSFG-SKIN, Laser Speckle Flowgraphy | May 23, 2017 | March 2, 2019 |
| NCT01095809 | Terminated | Phase 3 | Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema | April 2010 | April 2013 |
| NCT01095250 | Terminated | Phase 3 | Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis | April 2010 | October 2010 |
| NCT01093846 | Terminated | Phase 3 | 38 Week Extension Study to CAIN457C2303 | March 2010 | January 2011 |
| NCT01747538 | Terminated | Phase 3 | Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment | October 2012 | |
| NCT00889421 | Terminated | Phase 1/Phase 2 | Apremilast in the Treatment of Uveitis | November 2009 | June 2011 |
| NCT01684345 | Terminated | Phase 3 | Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis | August 2012 | |
| NCT00407316 | Unknown status | Quality of Life and Visual Function in Uveitis Patients | June 2006 | November 2006 | |
| NCT02252328 | Unknown status | Phase 2/Phase 3 | Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients | September 2015 | August 2019 |
| NCT02929251 | Unknown status | Phase 2 | Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis | June 28, 2017 | May 2019 |
| NCT02931175 | Unknown status | Phase 2 | ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) | January 2017 | December 2020 |
| NCT02934841 | Unknown status | Phase 2 | Conbercept in Choroidal Neovascularization Secondary to Uveitis | November 2016 | November 2018 |
| NCT01613963 | Unknown status | Causes of Visual Loss in Retinal Disease | May 2012 | December 2012 | |
| NCT03389191 | Unknown status | N/A | A Clinical Trial of Acyclovir for Viral Uveitis | January 2017 | December 2021 |
| NCT03525028 | Unknown status | N/A | A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis | November 1, 2018 | January 1, 2023 |
| NCT01261169 | Unknown status | Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study | January 2009 | December 2011 | |
| NCT03580343 | Unknown status | Phase 2 | Tofacitinib for Inflammatory Eye Disease | April 4, 2019 | April 4, 2021 |
| NCT03631108 | Unknown status | Feasibility Study and Preliminary Application Study on Iris OCTA | October 2018 | June 2019 | |
| NCT01025986 | Unknown status | Uveitis in Relation to Perceived Stress: A Prospective Study | July 2009 | ||
| NCT00893854 | Unknown status | Phase 1 | The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema | ||
| NCT00855608 | Unknown status | Phase 1 | Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study | March 2009 | March 2013 |
| NCT04101604 | Unknown status | Biomarkers of Common Eye Diseases | September 26, 2019 | October 1, 2021 | |
| NCT04150770 | Unknown status | Phase 4 | A Clinical Trial of Infliximab for Childhood Uveitis | January 2017 | December 2022 |
| NCT04162314 | Unknown status | Phase 2/Phase 3 | Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis | January 21, 2020 | December 2021 |
| NCT04588818 | Unknown status | Phase 2 | Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis | February 1, 2020 | December 31, 2023 |
| NCT04705103 | Unknown status | Development of AI Model for Uveitis Progression and Prognosis | January 10, 2021 | December 30, 2022 | |
| NCT00348153 | Unknown status | Phase 2/Phase 3 | Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) | August 2006 | March 2013 |
| NCT05102994 | Unknown status | Mutation Detection for VRL | November 10, 2021 | June 1, 2022 | |
| NCT05155592 | Unknown status | Phase 2 | Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients | January 1, 2021 | April 1, 2023 |
| NCT05370690 | Unknown status | Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020 | May 1, 2022 | November 1, 2022 | |
| NCT00012506 | Unknown status | Phase 3 | The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis | ||
| NCT00000119 | Unknown status | Phase 2 | Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis | March 1994 | |
| NCT00000124 | Unknown status | Phase 3 | Collaborative Ocular Melanoma Study (COMS) | November 1986 | |
| NCT00846625 | Withdrawn | Phase 2 | Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids | November 2009 | August 2011 |
| NCT00956124 | Withdrawn | Autofluorescence in Uveitic and Diabetic Macular Edema | October 2010 | June 1, 2016 | |
| NCT01103024 | Withdrawn | Phase 3 | Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis | December 2010 | February 2011 |
| NCT01280669 | Withdrawn | Phase 2 | Intravitreal Sirolimus as Therapeutic Approach to Uveitis | September 2022 | December 2024 |
| NCT01647152 | Withdrawn | Phase 1/Phase 2 | Ustekinumab for Active Sight-Threatening Uveitis | July 3, 2012 | June 30, 2015 |
| NCT01327664 | Withdrawn | Phase 3 | Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis | March 2011 | |
| NCT02311192 | Withdrawn | N/A | Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography | October 1, 2014 | September 30, 2016 |
| NCT02613442 | Withdrawn | Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis | April 2017 | April 13, 2017 | |
| NCT02598869 | Withdrawn | Phase 4 | Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema | November 30, 2015 | May 15, 2016 |
| NCT04721743 | Withdrawn | Microbiome as a ThErapeutic Response Biomarker | May 3, 2021 | May 3, 2021 | |
| NCT00499551 | Withdrawn | Phase 1/Phase 2 | A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis | September 2007 | September 2009 |
- Disase is a (Disease Ontology)
- DOID:3480
- Cross Reference ID (Disease Ontology)
- ICD10CM:H20.9
- Cross Reference ID (Disease Ontology)
- MESH:D014605
- Cross Reference ID (Disease Ontology)
- NCI:C26909
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:267719008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042164
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000554
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014605